Diagnostic Cytogenetics

Diagnostic Cytogenetics was paid $3.59M by Medicaid between Jul 2020 and Mar 2024, across 27 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 37% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Washington

Rank by total paid#14 of 76

Median peer was paid$90K

This provider vs. median40×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	8,882	$598K
2021	39,340	$1.79M
2022	57,591	$937K
2023	57,407	$234K
2024incomplete	3,441	$38K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	37%	20,611	18,110	$1.32M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	26%	24,086	5,756	$935K
87481		8.8%	17,565	5,150	$316K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	7.6%	3,397	2,917	$272K
87150		5.4%	4,470	1,817	$194K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	2.6%	6,223	1,667	$93K
87529		2.3%	6,802	4,067	$84K
87563		1.4%	8,234	5,178	$50K
87511		1.3%	6,103	4,117	$49K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.2%	18,151	15,979	$42K
87496		1.2%	6,362	4,228	$41K
87653		1.1%	8,270	5,133	$39K

15 more codes

87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.1%	6,583	$39K
87640		<1%	6,758	$32K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,812	$19K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	6,498	$18K
87641		<1%	2,381	$14K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	234	$11K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,463	$10K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,368	$8K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	420	$4K
88141		<1%	1,463	$3K
81005		<1%	2,321	$1K
81514		<1%	169	$1K
87500		<1%	615	$512.84
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	286	$193.53
88291		<1%	16	$173.94

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCDOUGAL, KYNDRA (CHIEF REGULATORY OFFICER)